Effect of human serum albumin on transplacental transfer of glyburide

Biochemical Pharmacology

Volumn 72, Issue 5, 2006, Pages 632-639

  Nanovskaya, Tatiana N ^a   Nekhayeva, Ilona ^a   Hankins, Gary D V ^a   Ahmed, Mahmoud S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Dual perfusion; Gestational diabetes; Glyburide; Human placenta; Human serum albumin; Transplacental transfer

Indexed keywords

GLIBENCLAMIDE; HUMAN SERUM ALBUMIN; PHENAZONE;

ARTICLE; CASE REPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DRUG DISTRIBUTION; DRUG RETENTION; DRUG TRANSPORT; FEMALE; FETUS CIRCULATION; HUMAN; HUMAN TISSUE; PLACENTA; PLACENTAL TRANSFER; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY;

EID: 33746767522     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.05.019     Document Type: Article

References (18)

1. Feldman J.M. Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects. Pharmacotherapy 5 (1985) 43-60
2. Langer O. Oral hypoglycemic agents and the pregnant diabetic: "From bench to bedside". Semin Perinatol 26 (2002) 215-224
3. Greene M.F. Oral hypoglycemic drugs for gestational diabetes. N Engl J Med 343 (2000) 1178-1179
4. Elliott B.D., Langer O., Schenker S., and Johnson R.F. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 165 (1991) 807-812
5. Elliott B.D., Schenker S., Langer O., Johnson R., and Prixoda T. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 171 (1994) 653-660
6. Langer O., Conway D.L., Berkus M.D., Xenakis E.M., and Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343 (2000) 1134-1138
7. Koren G. Glyburide and fetal safety: transplacental pharmacokinetic considerations. Reprod Toxicol 15 (2001) 227-229
8. Gedeon C, Koren G. Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta 2005; [Epub ahead of print].
9. Gedeon C, Behravan J, Koren G, Piquette-Miller M. Transport of glyburide by placental ABC transporters:Implications in fetal drug exposure. Placenta 2006; [Epub ahead of print].
10. Miller R.K., Wier P.J., Maulik D., and Di Sant'Agnese P.A. Human placenta in vitro:characterization during 12 h of dual perfusion. Contr Gynec Obstet 13 (1985) 77-84
11. Nanovskaya T.N., Deshmukh S., Brooks M., and Ahmed M. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 300 (2002) 26-33
12. Bourget P., Roulot C., and Fernandez H. Models for placental transfer studies of drugs. Clin Pharmacokinet 28 (1995) 161-180
13. Hytten F.E., and Leitch I. The physiology of human pregnancy (1971), Blackwell Scientific Publications, Oxford
14. Pritchard J.A., and Macdonald P.C. Williams obstetrics. 15th ed. (1976), Appleton-Century-Crofts, New York
15. Nekhayeva I.A., Nanovskaya T.N., Desmukh S.V., Zharikova O.L., Hankins G.D.V., and Ahmed M.S. Bidirectional transfer of methadone across human placenta. Biochem Pharmacol 69 (2005) 187-197
16. Nanovskaya T., Nekhayeva I., Karunaratne N., Audus K., Hankins G.D.V., and Ahmed M.S. Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol 69 (2005) 1869-1878
17. Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol. 2006; [Epub ahead of print].
18. Sastry B.V.R. Techniques to study human placental transport. Ad Drug Deliv Rev 38 (1999) 17-39